Table 3 Pre- and post-treatment outcomes in OnabotulinumtoxinA 195 U treated group
| Â | Headache days | Migraine days | Medication intake days | HIT-6 |
|---|---|---|---|---|
Baseline (1st injection) | 22.2 ± 4.9 | 21.6 ± 4.8 | 21.0 ± 5.1 | 67.9 ± 4.2 |
3 months (2nd injection) | 14.1 ± 3.4* | 13.5 ± 3.6* | 13.8 ± 3.2* | -- |
6 months (3rd injection) | 10.2 ± 2.8* | 9.7 ± 2.7* | 9.9 ± 1.9* | 61 ± 3.9* |
9 months (4th injection) | 7.4 ± 2.2* | 6.9 ± 1.6* | 7.0 ± 1.6* | -- |
12 months (5th injection) | 5.7 ± 1.7* | 5.4 ± 1.2* | 5.6 ± 1.4* | 56.8 ± 3.8* |
15 months (6th injection) | 5.4 ± 1.2* | 4.8 ± 1.0* | 5.1 ± 1.3* | -- |
18 months (7th injection) | 4.9 ± 1.3* | 4.5 ± 1.0* | 4.7 ± 1.3* | 54 ± 4.6* |
21 months (8th injection) | 4.4 ± 1.2* | 4.1 ± 1.0* | 4.2 ± 1.4* | -- |
24 months | 4.1 ± 1.0* | 3.8 ± 1.0* | 3.7 ± 1.3* | 49 ± 6.7* |